Trials / Completed
CompletedNCT03168750
Analysis of a Tapered Porous Coated Stem and a Cementless Hemispherical Acetabular Component
Prospective, Multicenter Study to Assess Performance of a Tapered Porous Coated Stem and a Cementless Hemispherical Acetabular Component in Total Hip Arthroplasty
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 120 (actual)
- Sponsor
- Medacta USA · Industry
- Sex
- All
- Age
- 75 Years
- Healthy volunteers
- Accepted
Summary
This prospective study will evaluate the hip function and quality of life of patients operated for total hip arthroplasty with Masterloc femoral stem and MPACT acetabular cup. The results of this study will establish the performance of Masterloc femoral component (Medacta International SA) and MPACT acetabular component (Medacta International SA), and provide a general estimate of survivorship, clinical effectiveness and complications.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Femoral Component:Medacta Masterloc Stem and Medacta MPACT cup. | Total hip arthroplasty (THA) is one of the most commonly performed and successful orthopaedic operations in improving a patient's quality of life. Orthopaedic surgeons are continually striving to improve all aspects of care relating to this procedure whether this is improvements in implant technology, instrument improvement, or the technique involved in performing the procedure.The results of this study will establish the performance of the femoral component and acetabular component, and provide a general estimate of survivorship, clinical effectiveness and complications. |
Timeline
- Start date
- 2017-07-25
- Primary completion
- 2024-11-13
- Completion
- 2024-11-13
- First posted
- 2017-05-30
- Last updated
- 2024-11-21
Locations
3 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03168750. Inclusion in this directory is not an endorsement.